Monday
Nov022009
New H1N1 Vaccine Study Shows Good News For Pregnant Women
By Laura Smith - University of New Mexico/Talk Radio News Service
Health officials announced today that there are about 30 million doses of the H1N1 vaccine available for states to order.
The annoucement was coupled with good news for people who health officials believe are at serious risk of contracting the virus. Anthony Facui, Director of the National Institute of Allergy and Infectious Diseases, said that results from a series of vaccine tests done on groups such as pregnant women were encouraging.
“The data show that nearly all the pregnant women who received a single 15 microgram dose have a robust immune response that is likely predictive of protection,” Facui said.
He added that children between six months and nine-years-old who receive a 15 microgram dose of the vaccine had a “less robust immune response” and would most likely need a second dose of vaccine.
Not all of the news surrounding H1NI is positive, however. Anne Schuchat, Director of the National Center for Immunization and Respiratory Diseases at the Center for Disease Control and Prevention, said that the virus has spread to all but two states in the U.S. Schuchat was hopeful that, as the number of hospitalizations and deaths as a result of the virus continue to increase, so will the medical response nationwide.
“We expect more vaccine doses to become available and eventually shipped out to the states for use,” she said.
A full report on the study was posted today on flu.gov.
Health officials announced today that there are about 30 million doses of the H1N1 vaccine available for states to order.
The annoucement was coupled with good news for people who health officials believe are at serious risk of contracting the virus. Anthony Facui, Director of the National Institute of Allergy and Infectious Diseases, said that results from a series of vaccine tests done on groups such as pregnant women were encouraging.
“The data show that nearly all the pregnant women who received a single 15 microgram dose have a robust immune response that is likely predictive of protection,” Facui said.
He added that children between six months and nine-years-old who receive a 15 microgram dose of the vaccine had a “less robust immune response” and would most likely need a second dose of vaccine.
Not all of the news surrounding H1NI is positive, however. Anne Schuchat, Director of the National Center for Immunization and Respiratory Diseases at the Center for Disease Control and Prevention, said that the virus has spread to all but two states in the U.S. Schuchat was hopeful that, as the number of hospitalizations and deaths as a result of the virus continue to increase, so will the medical response nationwide.
“We expect more vaccine doses to become available and eventually shipped out to the states for use,” she said.
A full report on the study was posted today on flu.gov.
H1N1 Vaccine Production Plodding, But 49.9 Million Doses Available
Anne Schuchat, Director of the Center for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases acknowledged the slow production of H1N1 vaccines, but says there are nearly 50 million doses available to the States for use.
“Like everyone, I’m disappointed in the initial production,” said Schuchat during a hearing with the House Energy and Commerce Committee. "However, today we can announce there are 49.9 million doses available of H1N1 vaccine for the states to order."
"Its not as much as we wanted to have by now, or, frankly what we needed to have by now, but every dose is being rapidly moved out," Schuchat added.
Chairman Henry Waxman (D-Calif.) praised the initial response to the virus, but also recognized the dangers posed by the vaccine shortage.
“The hope was that a robust vaccine supply would arrive before infections began to soar and everyone worked as quickly as possible to meet that goal. These hopes were not met. The past several weeks have reminded us that the process of making flu vaccines is unpredictable and challenging,” said Waxman.
Assistant Secretary for Preparedness and Response Nicole Lurie was grilled by Rep. Greg Walden (R-Oregon), who was diagnosed in late October with H1N1.
"We had testimony September 15 from Secretary Sebelius and everything seemed to be on track and fine. So, explain who, did the manufacturers, weren't they straight with you?" asked Walden.
"There's nobody to blame here, there's no smoking gun," Lurie said.
CDC estimates nearly 22 million Americans have been infected with H1N1. Of the 22 million infected, 98,000 were hospitalized and nearly 4,000 have dead.